This presented study aims to design the drugs which reduce various types of side effect and toxicity and also give the potent anticonvulsant activity. Epilepsy is a central nervous system (CNS) disorder characterized by the existence of more than one epileptic seizure which is associated with neurobiological, cognitive, psychological, and social disturbances. The medicine used to treat epilepsy in the past had various side effects such as ataxia, drowsiness, gastrointestinal disturbances etc. Owing to these side effects, we had an interest in the development of anticonvulsant drugs. To design and synthesize some N-containing heterocyclic moieties i.e. triazinone derivatives which may enhance the anticonvulsant activity of compounds to some extent. A series of 2-(2-amino-3-phenylpropanoyl)-5-((1, 5-disubstituted-1H-pyrazol-4-yl) methylene)-3-phenyl-1, 2-dihydro-1, 2, 4-triazin-6(5H)-one derivatives were designed and synthesized using the appropriate synthetic route and keeping all the view in the structural requirements of pharmacophoric pattern and evaluated for anticonvulsant activity and CNS activities.
